Want to track AIM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AIM ImmunoTech Inc. (AIM) Statistics
Valuation metrics
Market Cap 921.68K
Enterprise value -8.63M
Trailing P/E (ttm) -0.31
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 10.22
Price/Book (mrq) 0.63
Enterprise Value/Revenue -90.83
Enterprise Value/EBITDA 0.91
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 565.56K
Average volume (90 days) 32.2M
Price summary
52-Week low 0.21
52-Week high 2.89
Beta -
50-Day moving average 0.26
200-Day moving average 0.7
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1,031:1,000
Last split Date 10 Feb 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -150.21%
Operating margin -79.4%
Operational effectiveness
Return on assets -1.12%
Return on equity 9.53%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.01
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.83
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.58
Total debt (mrq) -
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 2.11%
Book value per share (mrq) 0.45
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
